Olema Pharmaceuticals, Inc.OLMANASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+94.7%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+94.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
7.4x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $16.25M | +27.1% |
| 2024 | $12.78M | +53.9% |
| 2023 | $8.31M | +277.4% |
| 2022 | $2.20M | +457.2% |
| 2021 | $395000.00 | +166.6% |
| 2020 | $-593000.00 | -8571.4% |
| 2019 | $7000.00 | +105.9% |
| 2018 | $-118000.00 | - |